Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Prepaid Assets (2018 - 2025)

Abvc Biopharma (ABVC) has disclosed Prepaid Assets for 12 consecutive years, with $346616.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 260.26% year-over-year to $346616.0, compared with a TTM value of $346616.0 through Dec 2025, up 260.26%, and an annual FY2025 reading of $346616.0, up 260.26% over the prior year.
  • Prepaid Assets was $346616.0 for Q4 2025 at Abvc Biopharma, down from $447280.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.3 million in Q2 2022 and bottomed at $96213.0 in Q4 2024.
  • Average Prepaid Assets over 5 years is $381330.8, with a median of $316898.5 recorded in 2022.
  • The sharpest move saw Prepaid Assets surged 892.88% in 2021, then crashed 88.63% in 2023.
  • Year by year, Prepaid Assets stood at $528354.0 in 2021, then crashed by 71.57% to $150235.0 in 2022, then plummeted by 32.74% to $101051.0 in 2023, then dropped by 4.79% to $96213.0 in 2024, then skyrocketed by 260.26% to $346616.0 in 2025.
  • Business Quant data shows Prepaid Assets for ABVC at $346616.0 in Q4 2025, $447280.0 in Q3 2025, and $194999.0 in Q2 2025.